Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$54,791,850
+$21,999,337 QoQ
Shares Held
415,909
+79.9% QoQ
Ownership
0.414%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 83.22012747980928.ToString("F0")%
Shared 0.ToString("F0")%
None 16.779872520190715.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Man Group plc holds $362,228,781 across 31 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
783,624 | $92,632,192 | |
| 2 | VTRS |
Viatris Inc
|
4,092,860 | $55,294,537 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
415,909 | $54,791,850 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
77,495 | $45,952,984 | |
| 5 | ALKS |
Alkermes plc.
|
625,046 | $22,101,626 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
208,694 | $16,048,568 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,293,300 | $12,312,216 | |
| 8 | PRGO |
PERRIGO Co plc
|
986,046 | $10,590,134 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,791,850 | 415,909 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,792,513 | 231,210 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,347,196 | 80,832 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,935,834 | 47,226 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,080,792 | 100,188 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,814,886 | 145,164 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $34,125,744 | 296,179 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $32,108,085 | 233,225 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,963,836 | 289,761 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,956,863 | 318,434 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $37,630,350 | 334,492 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $59,479,442 | 630,747 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $64,711,969 | 639,320 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $37,739,456 | 315,970 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,225,015 | 105,687 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,772,526 | 28,442 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $23,185,592 | 247,313 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,892,559 | 233,563 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $201,955 | 2,107 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,137,987 | 188,623 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,566,088 | 94,804 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,124,713 | 47,657 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||